Back to
Janus Henderson Group Ltd.
FL3
14 quarters
Position history for
Janus Henderson Group Ltd.'s holdings in AVADEL PHARMACEUTICALS PLC
As of its Q1 2024 13F, Janus Henderson held 12,915,160 shares of FL3 (Avadel Pharmaceuticals), worth $218.2M. Janus Henderson's 13F filings listed FL3 from Q4 2022 to Q1 2024, 6 quarterly filings. FL3 was 0.1% of Janus Henderson's reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$1.5M
Total Shares Change
-229,402
Quarter-by-Quarter History
Other major holders of FL3: RTW Investments, LP, Polar Capital Holdings Plc